Viewing Study NCT04742985



Ignite Creation Date: 2024-05-06 @ 3:46 PM
Last Modification Date: 2024-10-26 @ 1:56 PM
Study NCT ID: NCT04742985
Status: COMPLETED
Last Update Posted: 2021-08-02
First Post: 2021-02-03

Brief Title: Effects of Green Tea Extracts on Gastric Mucosal Protection
Sponsor: Pusan National University Yangsan Hospital
Organization: Pusan National University Yangsan Hospital

Study Overview

Official Title: Effects of Combined Extracts of Green Tea Seed Saponins and Green Tea Leaves Epigallocatechin-3-gallate on Gastric Mucosal Protection A Pilot Study
Status: COMPLETED
Status Verified Date: 2021-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The investigators conduct a randomized double-blind placebo-controlled pilot study to investigate the effects of a combined extract of green tea seed saponins and green tea leaves epigallocatechin-3-gallate on gastric mucosal protection in adults with functional dyspepsia for 8 weeks
Detailed Description: A previous study has indicated that combined extract of green tea seed saponins and green tea leaves epigallocatechin-3-gallate may improve gastric mucosal status in rat with alcohol-induced gastritisTherefore the investigators conduct a randomized double-blind placebo-controlled pilot study to investigate the effects of a combined extract of green tea seed saponins and green tea leaves epigallocatechin-3-gallate on gastric mucosal protection in adults with functional dyspepsia for 8 weeks the safety of the compound are also evaluated The Investigators examine C-reactive protein IFN-γ TNF-α gastrin malondialdehyde 8-hydroxy-2 -deoxyguanosine and questionnaires Gastrointestinal Symptom Rating Scale Nepean dyspepsia index-Korean version Nepean dyspepsia index-Korean version QOL questionnaire Gastrointestinal symptom scale at baseline and after 8 weeks of intervention Twenty four adults were administered either 320 mg of combined extracts of green tea seed saponins and green tea leaves epigallocatechin-3-gallate or a placebo each day for 8 weeks

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None